Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

HKG:3613 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,392	7,350	10,162	9,593	11,234	6,822
Market Cap Growth	10.38%	-27.68%	5.93%	-14.61%	64.66%	-30.70%
Enterprise Value	5,705	5,854	7,971	7,478	9,519	5,203
Last Close Price	8.83	8.43	11.26	10.41	11.55	6.89
PE Ratio	14.34	14.69	18.81	14.85	18.48	12.58
Forward PE	13.80	10.53	12.37	15.43	17.23	12.43
PS Ratio	4.33	4.56	6.66	5.54	7.22	5.19
PB Ratio	1.75	1.73	2.53	2.57	3.17	2.18
P/TBV Ratio	1.87	1.83	2.67	2.71	3.35	2.30
P/FCF Ratio	14.25	-	23.15	18.85	14.90	66.13
P/OCF Ratio	13.03	-	22.05	17.52	14.46	58.79
PEG Ratio	-	0.69	0.69	0.69	0.69	0.69
EV/Sales Ratio	3.34	3.63	5.23	4.32	6.12	3.96
EV/EBITDA Ratio	8.41	9.87	12.44	9.13	12.10	7.81
EV/EBIT Ratio	9.67	10.20	12.78	9.30	12.33	8.08
EV/FCF Ratio	11.00	-	18.16	14.69	12.63	50.43
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.03
Debt / EBITDA Ratio	0.21	0.19	0.19	0.12	0.15	0.15
Debt / FCF Ratio	0.28	-	0.30	0.20	0.17	1.03
Asset Turnover	0.39	0.36	0.35	0.43	0.43	0.40
Inventory Turnover	0.41	0.42	0.65	1.29	0.94	0.89
Quick Ratio	11.32	10.02	8.55	7.66	13.31	11.14
Current Ratio	18.17	16.85	11.65	8.80	15.38	13.54
Return on Equity (ROE)	13.06%	12.80%	15.22%	19.00%	19.54%	19.27%
Return on Assets (ROA)	8.24%	7.98%	9.01%	12.48%	13.31%	12.27%
Return on Invested Capital (ROIC)	20.85%	22.48%	32.14%	45.58%	47.11%	47.43%
Return on Capital Employed (ROCE)	13.40%	13.30%	15.20%	21.10%	21.30%	20.10%
Earnings Yield	6.97%	6.81%	5.32%	6.73%	5.41%	7.95%
FCF Yield	7.02%	-3.54%	4.32%	5.30%	6.71%	1.51%
Dividend Yield	3.97%	4.15%	2.93%	3.17%	2.42%	3.48%
Payout Ratio	56.85%	55.22%	51.12%	36.29%	33.05%	35.49%
Total Shareholder Return	3.88%	4.15%	2.93%	3.17%	2.42%	3.48%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.